• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Alkermes plc - Ordinary Shares (NQ:ALKS)

    30.41 -0.32 (-1.04%)
    Streaming Delayed Price Updated: 12:03 PM EST, Feb 27, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about Alkermes plc - Ordinary Shares

    < Previous 1 2 Next >
    News headline image
    Alkermes plc Reports Financial Results for the Fourth Quarter and Year Ended Dec. 31, 2025 and Provides Financial Expectations for 2026
    From Alkermes plc
    Via Business Wire
    News headline image
    Alkermes plc Announces CEO Succession Plan
    From Alkermes plc
    Via Business Wire
    News headline image
    Alkermes to Present at the TD Cowen 46th Annual Health Care Conference
    From Alkermes plc
    Via Business Wire
    News headline image
    Alkermes Honors Women's Equality Day
    Via ACCESSWIRE
    News headline image
    Alkermes plc Completes Acquisition of Avadel Pharmaceuticals plc, Accelerating Entry Into Sleep Medicine Market
    From Alkermes plc
    Via Business Wire
    News headline image
    Alkermes to Report Fourth Quarter and Year-End Financial Results on Feb. 25, 2026
    From Alkermes plc
    Via Business Wire
    News headline image
    Alixorexton Granted Breakthrough Therapy Designation by U.S. FDA for the Treatment of Narcolepsy Type 1
    From Alkermes plc
    Via Business Wire
    News headline image
    Alkermes to Present at the 44th Annual J.P. Morgan Healthcare Conference
    From Alkermes plc
    Via Business Wire
    News headline image
    Alkermes to Participate in Two Upcoming Investor Conferences
    From Alkermes plc
    Via Business Wire
    News headline image
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Avadel Pharmaceuticals plc (Nasdaq – AVDL), Middlefield Banc Corp. (Nasdaq – MBCN), Heidrick & Struggles International, Inc. (Nasdaq - HSII), Comerica Incorporated
    From Brodsky & Smith LLC
    Via GlobeNewswire
    News headline image
    Sarissa Capital Urges Alkermes Shareholders to Vote “FOR” Sarah Schlesinger and “WITHHOLD” Incumbent Director Richard Gaynor
    From Sarissa Capital Management LP
    Via Business Wire
    News headline image
    Sarissa Issues Presentation Highlighting Sarissa Nominees Are Qualified to Create Value for Alkermes Shareholders
    From Sarissa Capital Management LP
    Via Business Wire
    News headline image
    Independent Proxy Advisory Firm ISS Agrees With Sarissa Capital That Shareholders’ Interests Would Be Best Served With Direct Shareholder Representation on the Alkermes Board
    From Sarissa Capital Management LP
    Via Business Wire
    News headline image
    Independent Proxy Advisory Firm ISS Concludes That Sarissa Capital Has Made a Compelling Case for Change to the Alkermes Board
    From Sarissa Capital Management LP
    Via Business Wire
    News headline image
    Sarissa Issues Presentation Highlighting the Need for Shareholder Representation on the Alkermes Board
    From Sarissa Capital Management LP
    Via Business Wire
    News headline image
    Sarissa Urges Shareholders to Vote for Sarissa Nominees to Provide Much Needed Oversight and Accountability to Alkermes
    From Sarissa Capital Management LP
    Via Business Wire
    News headline image
    Sarissa Capital Highlights Misleading Claims Made by Alkermes in Its Attempt to Thwart Shareholder Representation on the Board
    From Sarissa Capital Management LP
    Via Business Wire
    News headline image
    Sarissa Urges Alkermes Shareholders to Vote the Universal Blue Card to Upgrade Alkermes for the Benefit of Shareholders
    From Sarissa Capital Management LP
    Via Business Wire
    News headline image
    Sarissa Capital Comments on Alkermes Annual Meeting
    From Sarissa Capital Management LP
    Via Business Wire
    News headline image
    Alkermes Announces 2022 Alkermes Inspiration Grants® Program to Support Innovative Programs Focused on People Affected by Addiction, Serious Mental Illness or Cancer
    SOURCE: Alkermes 
    Via 3BL Media
    Small-Cap Psychedelic Play Vying for Future Leadership in Addiction Treatment (AXSM, AWKNF, BICX, OPNT, ALKS, PFE, AMPH, OMER)
    Via AB Newswire
    News headline image
    Sarissa Condemns Poor Corporate Governance at Alkermes
    From Sarissa Capital Management LP
    Via Business Wire
    News headline image
    New Findings About Life With Bipolar 1 Disorder
    SOURCE: Alkermes 
    Via 3BL Media
    Global Central Nervous System Treatment Market Is Expected to Reach $166 Billion In 2028
    Palm Beach, FL – May 26, 2022 – FinancialNewsMedia.com News Commentary – Worldwide, there is a rapid increase in the prevalence and incidence of neurological disorders such as multiple sclerosis,... 
    Via FinancialNewsMedia
    News headline image
    Treating Bipolar 1 Disorder
    SOURCE: Alkermes 
    Via 3BL Media
    News headline image
    Alkermes Awarded 2022 Platinum Bell Seal for Workplace Mental Health
    SOURCE: Alkermes 
    Via 3BL Media
    News headline image
    Tips to Improve Mental Well-Being
    SOURCE: Alkermes 
    Via 3BL Media
    News headline image
    Alkermes Celebrates National Women's Health Week by Reminding You Why Regular Cancer Screenings Are Vital
    SOURCE: Alkermes 
    Via 3BL Media
    News headline image
    Alkermes to Highlight Data Related to Psychiatry Portfolio at Upcoming Scientific Conferences During Mental Health Awareness Month
    SOURCE: Alkermes 
    Via 3BL Media
    News headline image
    LGBTQ+ People Are More Likely to Experience a Mental Health Condition
    SOURCE: Alkermes 
    Via 3BL Media
    Topics LGBTQ
    < Previous 1 2 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.